Quantitative Prostate MRI
- PMID: 32410356
- DOI: 10.1002/jmri.27191
Quantitative Prostate MRI
Abstract
Prostate MRI is reported in clinical practice using the Prostate Imaging and Data Reporting System (PI-RADS). PI-RADS aims to standardize, as much as possible, the acquisition, interpretation, reporting, and ultimately the performance of prostate MRI. PI-RADS relies upon mainly subjective analysis of MR imaging findings, with very few incorporated quantitative features. The shortcomings of PI-RADS are mainly: low-to-moderate interobserver agreement and modest accuracy for detection of clinically significant tumors in the transition zone. The use of a more quantitative analysis of prostate MR imaging findings is therefore of interest. Quantitative MR imaging features including: tumor size and volume, tumor length of capsular contact, tumor apparent diffusion coefficient (ADC) metrics, tumor T1 and T2 relaxation times, tumor shape, and texture analyses have all shown value for improving characterization of observations detected on prostate MRI and for differentiating between tumors by their pathological grade and stage. Quantitative analysis may therefore improve diagnostic accuracy for detection of cancer and could be a noninvasive means to predict patient prognosis and guide management. Since quantitative analysis of prostate MRI is less dependent on an individual users' assessment, it could also improve interobserver agreement. Semi- and fully automated analysis of quantitative (radiomic) MRI features using artificial neural networks represent the next step in quantitative prostate MRI and are now being actively studied. Validation, through high-quality multicenter studies assessing diagnostic accuracy for clinically significant prostate cancer detection, in the domain of quantitative prostate MRI is needed. This article reviews advances in quantitative prostate MRI, highlighting the strengths and limitations of existing and emerging techniques, as well as discussing opportunities and challenges for evaluation of prostate MRI in clinical practice when using quantitative assessment. LEVEL OF EVIDENCE: 5 TECHNICAL EFFICACY: Stage 2.
Keywords: MRI; PI-RADS; diffusion weighted imaging; machine learning; prostate cancer; texture analysis.
© 2020 International Society for Magnetic Resonance in Medicine.
Similar articles
-
Improvement of PI-RADS-dependent prostate cancer classification by quantitative image assessment using radiomics or mean ADC.Magn Reson Imaging. 2021 Oct;82:9-17. doi: 10.1016/j.mri.2021.06.013. Epub 2021 Jun 18. Magn Reson Imaging. 2021. PMID: 34147597
-
Prostate Cancer Differentiation and Aggressiveness: Assessment With a Radiomic-Based Model vs. PI-RADS v2.J Magn Reson Imaging. 2019 Mar;49(3):875-884. doi: 10.1002/jmri.26243. Epub 2018 Sep 19. J Magn Reson Imaging. 2019. PMID: 30230108 Free PMC article.
-
Transition zone prostate cancer: Logistic regression and machine-learning models of quantitative ADC, shape and texture features are highly accurate for diagnosis.J Magn Reson Imaging. 2019 Sep;50(3):940-950. doi: 10.1002/jmri.26674. Epub 2019 Jan 30. J Magn Reson Imaging. 2019. PMID: 30701625
-
Prostate imaging reporting and data system version 2 (PI-RADS v2): a pictorial review.Abdom Radiol (NY). 2017 Jan;42(1):278-289. doi: 10.1007/s00261-016-0871-z. Abdom Radiol (NY). 2017. PMID: 27522352 Free PMC article. Review.
-
Update on the ICUD-SIU consultation on multi-parametric magnetic resonance imaging in localised prostate cancer.World J Urol. 2019 Mar;37(3):429-436. doi: 10.1007/s00345-018-2395-3. Epub 2018 Jul 12. World J Urol. 2019. PMID: 30003373 Review.
Cited by
-
Comparison of Diffusion Kurtosis Imaging and Standard Mono-Exponential Apparent Diffusion Coefficient in Diagnosis of Significant Prostate Cancer-A Correlation with Gleason Score Assessed on Whole-Mount Histopathology Specimens.Diagnostics (Basel). 2023 Jan 4;13(2):173. doi: 10.3390/diagnostics13020173. Diagnostics (Basel). 2023. PMID: 36672983 Free PMC article.
-
MRI-Based Surrogate Imaging Markers of Aggressiveness in Prostate Cancer: Development of a Machine Learning Model Based on Radiomic Features.Diagnostics (Basel). 2023 Aug 28;13(17):2779. doi: 10.3390/diagnostics13172779. Diagnostics (Basel). 2023. PMID: 37685317 Free PMC article.
-
Impact of magnetic resonance imaging visibility of prostate cancer on partial gland ablation.BJUI Compass. 2025 Aug 6;6(8):e70065. doi: 10.1002/bco2.70065. eCollection 2025 Aug. BJUI Compass. 2025. PMID: 40777065 Free PMC article.
-
Amide proton transfer imaging has added value for predicting extraprostatic extension in prostate cancer patients.Front Oncol. 2024 Feb 29;14:1327046. doi: 10.3389/fonc.2024.1327046. eCollection 2024. Front Oncol. 2024. PMID: 38496759 Free PMC article.
-
Generalizable, sequence-invariant deep learning image reconstruction for subspace-constrained quantitative MRI.Magn Reson Med. 2025 Jul;94(1):89-104. doi: 10.1002/mrm.30433. Epub 2025 Jan 20. Magn Reson Med. 2025. PMID: 39834093 Free PMC article.
References
-
- Hegde JV, Mulkern RV, Panych LP, et al. Multiparametric MRI of prostate cancer: An update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer. J Magn Reson Imaging 2013;37(5):1035-1054.
-
- National Comprehensive Cancer Network. Clinical practice guidelines in oncology: Prostate cancer. Fort Washington, PA: National Comprehensive Cancer Network; 2012.
-
- Morash C, Tey R, Agbassi C, et al. Active surveillance for the management of localized prostate cancer: Guideline recommendations. Can Urol Assoc J 2015;9(5-6):171-178.
-
- Gaur S, Turkbey B. Prostate MR imaging for posttreatment evaluation and recurrence. Radiol Clin North Am 2018;56(2):263-275.
-
- Kasivisvanathan V, Rannikko AS, Borghi M, et al. MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med 2018;378(19):1767-1777.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous